Parametrica Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,723
Closed -$217K 315
2018
Q3
$217K Buy
+5,723
New +$216K 0.48% 125
2018
Q2
Sell
-6,292
Closed -$212K 152
2018
Q1
$212K Buy
6,292
+526
+9% +$20.2K 0.26% 185
2017
Q4
$256K Sell
5,766
-322
-5% -$14.7K 0.16% 267
2017
Q3
$305K Buy
+6,088
New +$311K 0.13% 184
2017
Q2
Sell
-9,957
Closed -$553K 346
2017
Q1
$553K Sell
9,957
-10,079
-50% -$556K 0.58% 28
2016
Q4
$1.04M Buy
+20,036
New +$967K 1.03% 15

Other funds holding PBH

Parametrica Management's PBH Position: Q4 2018 in Review

Parametrica Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2018, closing a stake of 5,723 shares — an estimated $217K sold.

Parametrica Management first reported a position in PBH in Q4 2016 and held it in 6 quarters. The position peaked at $1.04M in Q4 2016. 241 funds tracked by Wall St. Rank hold PBH as of Q4 2018.

  • Parametrica Management reported no remaining Prestige Consumer Healthcare position as of Q4 2018 after selling out during the quarter.
  • Parametrica Management sold 5,723 Prestige Consumer Healthcare shares in Q4 2018, an estimated $217K.
  • Parametrica Management first reported a position in Prestige Consumer Healthcare in Q4 2016 and held it in 6 quarters.
  • Parametrica Management's Prestige Consumer Healthcare position peaked at $1.04M in Q4 2016.
  • 241 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2018.

Based on Parametrica Management's 13F filing for Q4 2018, filed 12 Feb 2019.